Selective ALK5 inhibitor, IC50 = 59, 400 and 1400 nM for TGF-beta RI, TGF-beta RII and MLK-7K, respectively1. Inhibits Smad2 phosphorylation induced by TGF-beta as well as fibronectin expression and MDA-MB-231 cell invasion2. Abolishes resistance of glioblastoma-
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten